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Investigating the Risk of Cancer in 1990–1991 US Gulf War Veterans
With the Use of State Cancer Registry Data
HEATHER A. YOUNG, PHD, JESSICA D. MAILLARD, MPH, PAUL H. LEVINE, MD,
SAMUEL J. SIMMENS, PHD, CLARE M. MAHAN, PHD, AND HAN K. KANG, DRPH
PURPOSE: The purpose of this study was to determine whether proportional cancer incidence is greater
among Gulf War veterans compared with non-Gulf War veterans.
METHODS: Files obtained from the Defense Manpower Data Center included data for 621,902 veterans
who were deployed to the Persian Gulf during the 1990 to 1991 Gulf War (August 2, 1990, to March 1,
1991) and 746,248 non-Gulf War veteran controls. Identification of veterans who received a cancer diag-
nosis between 1991 and 2006 was accomplished through record linkage of the Defense Manpower Data
Center dataset with files from 28 state cancer registries and the Department of Veterans Affairs Central
Cancer Registry. By the use of logistic regression, proportional incidence ratios adjusted for demographic
and military characteristics were calculated by comparing the proportion of a specific cancer among all
cancers in the Gulf War veterans to the proportion of that specific cancer among all cancers in the non-
Gulf War veterans.
RESULTS: Only lung cancer showed a statistically significant relative excess among Gulf War veterans
compared with non-Gulf War veterans (adjusted proportional incidence ratios, 1.15; 95% confidence
interval, 1.031.29). When adjusted for race, age, and sex, the overall proportion of cancers among
Gulf War and non-Gulf War veterans was similar (odds ratio, 0.99; 95% CI, 0.961.02).
CONCLUSIONS: With the exception of lung cancer, there is little evidence of excess risk of cancer asso-
ciated withGulfWar deployment. A follow-up study is warranted to confirm this finding and to evaluate the
role of greater smoking rates among deployed personnel.
Ann Epidemiol 2010;20:265–272.  2010 Elsevier Inc. All rights reserved.
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INTRODUCTION
The 1996 Presidential Advisory Committee on Gulf War
Veterans’ Illnesses reported that a number of Gulf military
personnel from Operation Desert Storm may have been
exposed to potential human carcinogens such as chemical
warfare agents, aflatoxin, and certain petroleum products,
including smoke from oil well fires (1). Therefore, the Pres-
idential Advisory Committee recommended developing
long-term studies for investigating increased rates of lung,
liver, and other cancers among Gulf War veterans.
A few studies have attempted to compare cancer inci-
dence for Gulf War veterans and non-Gulf War comparison
groups. One of the first used the Department of Defense
(DOD) hospitalization database and reported increased risks
of hospitalization for testicular cancer shortly after return
from the Gulf War (2). A subsequent study of the DOD
hospitalization data found that the increased risks did not
persist during a 4-year follow-up period (3). A pilot study
of matching records of approximately 1.4 million US Gulf
War era veterans with two state cancer registries was con-
ducted to compare cancer patterns among Gulf War and
non-Gulf War veterans. The study suggested that the
proportional incidence of testicular cancer was significantly
increased among Gulf War veterans (4). A cohort study of
1990 to 1991 UK Gulf War veterans found no excess risk
of any site-specific cancers or overall cancer (5). Also,
a survey of 30,000 Gulf War era veterans in 2005 showed
no significant difference in the incidence of cancer between
Gulf War veterans and non-Gulf War veterans (6).
Cancer mortality studies can be a useful proxy for inci-
dence for cancers with low survival rates. A mortality
follow-up study of the entire cohort of US Gulf War
veterans for 1990 to 1997 did not indicate any excess
mortality as the result of cancer among Gulf War veterans
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Selected Abbreviations and Acronyms
DOD Z Department of Defense
DMDC Z Defense Manpower Data Center
SEER Z Surveillance, Epidemiology, and End Results
PIR Z proportional incidence ratio
95% CI Z 95% confidence interval
SIR Z standardized incidence ratio
VACCR Z Veterans Affairs Central Cancer Registry
VA Z Veterans Affairs
compared with non-Gulf War veterans (7). A post war
(19911999) mortality study of UK Gulf War veterans
also reported no significant difference in the risk of cancer
mortality between those who were deployed and nonde-
ployed (8). However, more recent studies of the US Gulf
War veterans who have had potential exposure to nerve
agents reported an increased risk of brain cancer mortality
among those veterans who were exposed to the plume
from the 1991 Khamisiyah munitions destruction (9, 10).
This plume occurred when US troops destroyed a large
storage complex at Khamisiyah that contained stacks of
rockets loaded with nerve agents (11).
Limitations of these previous studies included focus on
mortality rather than incidence, reliance on hospitalization
data, relatively short follow-up periods, or small numbers
of observed cancers. This study was designed to partially
overcome these limitations by identifying incident cancers
obtained through matching of veterans’ data to data ob-
tained from cancer registries representing a large portion
of the US population for up to 15 years of follow-up.
The primary purpose of this study was to determine
whether the overall cancer pattern differed between Gulf
War and non-Gulf War veterans and to determine whether
proportional cancer incidence of specific cancers was greater
among Gulf War veterans in comparison with non-Gulf
War veterans. The secondary purpose was to determine
whether those cancers that showed significantly different
proportions between the Gulf War and non-Gulf War
veterans differed from the expected incidence in the general
population. Finally, for those cancers that showed relative
excess in the Gulf War veterans, the time of diagnosis
patterns were compared between Gulf War and non-Gulf
War veterans.
METHODS
Study Population
The study population included 621,902 veterans who were
deployed to the Persian Gulf during the 1990-1991 Gulf
War (August 2, 1990, to March 1, 1991) and 746,248
non-Gulf War controls. The former group represents the
entire population deployed during the time frame, whereas
the latter consists of a stratified random sample of veterans
from all military personnel who served during the conflict
but were not deployed to the Gulf region. The data source
for these veterans consisted of files obtained from the
Defense Manpower Data Center (DMDC). Both groups
included personnel on active duty, in the reserves, and in
the National Guard. The details for the selection of the
two study groups and their military and demographic char-
acteristics are detailed elsewhere (7, 12). Institutional
review board approval was obtained from The George
Washington University, the Department of Veterans
Affairs, and individual state registries where required.
Cancer Matching Methodology
Identification of military personnel who received a diagnosis
of cancer between January 1, 1991, and December 31, 2006,
was accomplished by record linkage of the DMDC database
with files at 28 state central cancer registries and
the Veterans Affairs Central Cancer Registry (VACCR).
Table 1 lists participating registries. The registries used
a variety of probabilistic record linkage software that weighs
the likelihood of subject identity on the basis of identical or
near identical information in the records. Uncertain
matches were hand reviewed. Key matching variables were
name, date of birth, Social Security number, sex, date of
death (if available), and race. Missing data on a single key
variable did not exclude the possibility of a match as other
variables could be used in the matching software algorithm.
All veterans in the cohort had data for Social Security
number.
The criteria for selection of collaborating state registries
were population size of the state and number of years since
1991 that the registry has been population based. On the
basis of 2000 Census data, the state registries that were
included captured 84% of the United States population.
Cancer type was determined using the International Classi-
fication of Diseases for Oncology, 3rd Edition (13) and in
one state (Kentucky), the Surveillance, Epidemiology, and
End Results (SEER) site recode (14). For analysis purposes,
cancers were grouped into 30 categories.
Statistical Analysis
To determine whether the proportion of Gulf War and non-
GulfWar veterans with a cancer diagnosis differed, a logistic
regression controlling for age, race, and sex was performed.
For this purpose, data from the VACCR were excluded as
the result of differences in the eligibility for VA care
between Gulf War and non-Gulf War veterans (Web
Appendix). Next, to determine whether there were differ-
ences in overall cancer pattern between Gulf War and
non-Gulf War veterans, the Mantel Haenszel procedure,
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which controlled for age, race, and sex, was used to provide
a global test of these differences.
To determine whether there were differences in specific
cancers, crude proportional incidence ratios (PIRs) and
95% confidence intervals (95% CIs) were then calculated.
The proportional incidence was calculated by comparing
the proportion of each specific cancer type among all
cancers in the Gulf War group with the proportion of that
specific cancer type among all cancers in the non-Gulf
War group. A subgroup analysis compared ground (Army
and Marines) Gulf War veterans with non-Gulf War
veterans. This analysis was of interest because it is believed
that the in-theater exposures of the ground troops differed
from those of the nonground (Air Force and Navy) troops
with regard to proximity, duration, and intensity of poten-
tial exposures such as smoke from oil well fires and Khami-
siyah munitions.
To control for potential confounding, adjusted PIRs were
computed through logistic regression analyses predicting
each specific cancer (against all other cancers) from Gulf
status while controlling for sex, diagnosis age, diagnosis
age squared, diagnosis year, race, branch of service, unit
type, and registry group. Diagnosis age squared was included
as a term in the model to improve the model fit. Because
registries varied on the years covered including starting
and ending year, a variable was created to categorize the
registries into similar groups based on years of coverage
and starting and stopping year. Assignment of registry
groups is detailed in Table 1.
For those cancers that showed statistically significant
adjusted PIRs, the study groups were compared with the
general population by use of the SEER database. Age,
race, and sex adjusted standardized incidence ratios (SIRs;
also known as observed versus expected ratios) were calcu-
lated by dividing, within 5-year age categories for white
male subjects, the observed number of cases of a specific
cancer by the expected number. The expected number
was based on the relative proportion of that specific cancer
extracted from the SEER incidence database for the years
1992 to 2006 (15). Exact 95% CIs around the SIRs were
calculated as an extension of the Poisson method (16).
The adjusted proportions of each cancer that showed
statistically significant adjusted PIRs were calculated and
plotted by year of diagnosis to examine time of diagnosis
patterns. These proportions were adjusted for race, age at
diagnosis, age squared, and sex through logistic regression
equations predicting each cancer type with mean values
for covariates substituted into the equations. Analyses
were conducted using SAS version 8.2 (17).
RESULTS
Descriptive Results
Table 2 shows the demographic characteristics of veterans
with cancer matches compared with all veterans stratified
by Gulf War versus non-Gulf War status. Racial distribu-
tions were similar between the Gulf War and non-Gulf
War cancer matches whereas Gulf War veterans were
slightly more likely to be male than non-Gulf War veterans.
Gulf War veterans were younger than non-Gulf War
veterans. Similarly, among the cancer matches the Gulf
War veterans were more likely to be younger in 1991 and
TABLE 1. Characteristics of data received from state cancer
registries used in comparison of US Gulf War and non-Gulf War
veterans, 19912006
Registry
group
numbera State
Starting
year
Ending
year
Total
years
% of US
populationb
1
Arizona 1991 2006 15 1.80
Georgia 1991 2006 15 2.86
Michigan 1991 2006 15 3.53
Tennessee 1991 2006 15 2.05
Texas 1991 2006 15 7.15
California 1991 2005 14 11.77
Colorado 1991 2005 14 1.53
Connecticut 1991 2005 14 1.23
North
Carolina
1991 2005 14 2.88
Virginia 1991 2005 14 2.50
2
Indiana 1991 2004 13 2.16
Iowa 1991 2004 13 1.05
Massachusetts 1991 2004 13 2.33
Wisconsin 1991 2004 13 1.92
Illinois 1991 2003 12 4.40
New York 1991 2003 12 6.86
Pennsylvania 1991 2003 12 4.49
Florida 1991 2002 11 5.90
Washington 1992 2003 11 2.08
3
Alabama 1996 2006 10 1.59
Kentucky 1994 2004 10 1.46
Oregon 1995 2005 10 1.24
Oklahoma 1996 2005 9 1.22
South
Carolina
1996 2005 9 1.43
Ohio 1996 2003 7 4.06
4
New Jersey 1991 1999 8 3.04
Maryland 1991 1998 7 1.88
All states combined 84.41
VACCRc 1991 2006 15
VACCRZVeterans Affairs Central Cancer Registry.
aRegistry group number is a variable created to categorize registries into similar
groups on the basis of starting year, ending year, and the total number of years of
data covered in this study.
bState population as a percent of US (excluding Puerto Rico) civilian population
ages 18 and older from US Census Bureau, Census 2000.
cData from the VACCR were included in group 1.
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at age of diagnosis compared to non-Gulf War veterans.
Those veterans who were cancer matches were much more
likely to be older in 1991 than the overall sample of
veterans.
Overall Cancer Patterns
The linkage process identified 21,075 matches of the total
number of approximately 1.4 million veterans, with 1.3%
Gulf War group having a cancer match (8,211 cancers/
621,902 Gulf War veterans) and 1.7% of the non-Gulf
War group having a cancer match (12,864 cancers/
746,248 non-Gulf War veterans). These proportions are
underestimates of the actual 15-year incidence because
not all states and years within states had registry data for
this study. Of the cancers, 1277 of the Gulf War matches
and 1519 of the non-Gulf war matches were identified
from the VACCR. After controlling for age, race, and sex,
there was no significant association between Gulf status
and the proportion of veterans with a cancer (odds ratio,
0.99; 95% CI, 0.961.02) identified from a state registry
(Supplemental Data). Although there was no difference in
the proportion of veterans with a cancer identified, there
was a significant difference in overall cancer patterns
between Gulf War and non-Gulf War veterans by the
Mantel Haenszel test of general association after controlling
for the same covariates as noted (p! .001). Similarly, there
was a significant difference in cancer patterns between the
ground group and non-Gulf War group (p! .001).
Specific Cancer Types
Table 3 shows the number of cancer matches in specific
primary site groupings for Gulf War and non-Gulf War as
well as the PIRs and 95% CIs comparing Gulf War with
non-Gulf War and ground with non-Gulf War after adjust-
ing for covariates. Lung cancer was found proportionally
more often in the Gulf War veterans compared with the
non-Gulf War veterans (PIR, 1.15; 95% CI, 1.031.29)
and ground troops compared with non-Gulf War veterans
(PIR, 1.21; 95% CI, 1.071.38). No other cancer groupings
showed significantly increased PIRs. However, testicular
cancer showed a significantly decreased PIR of 0.85 (95%
CI, 0.750.98) when comparing Gulf War veterans with
non-Gulf War veterans as did Kaposi sarcoma (PIR, 0.54;
95% CI, 0.370.79).
For those cancers that showed statistically significant
PIRs, SIRs comparing the Gulf and non-Gulf to the SEER
population are displayed in Table 4. Neither Gulf War nor
non-Gulf War veterans showed significantly increased risks
of lung or testicular cancer over the general population
whereas both Gulf War and non-Gulf War veterans showed
significantly decreased risks of Kaposi sarcoma when
compared with the general population.
Figure 1 shows the adjusted relative proportion of all
cancers that were lung cancers by group at each year of diag-
nosis. Although the trend in the figure suggests that the
overall incidence of lung cancer is flat or decreasing over
time, this is an artifact of controlling for age at diagnosis.
TABLE 2. Demographic and military characteristics of US Gulf
War and non-Gulf War veterans with matched cancer diagnoses
compared with all veterans, 19912006
Characteristic
(%)
All veterans in sample
used for matching
All matches from
cancer registries
Gulf War
veterans
(nZ 621,902)
Non-Gulf
War veterans
(nZ 746,248)
Gulf War
veterans
(nZ 8,211)
Non-Gulf
War veterans
(nZ 12,864)
Racea
White 67.4 69.4 69.0 71.8
Black 23.0 21.4 23.0 21.4
Hispanic 5.0 4.9 4.0 3.6
Other 4.3 3.8 3.0 2.6
Sexa
Male 92.7 86.3 88.0 82.5
Female 7.0 13.3 12.0 17.2
Service branch
Air Force 11.5 11.3 13.0 13.0
Army 51.8 55.7 59.0 59.7
Marine 14.8 15.3 10.0 10.3
Navy 21.9 17.7 19.0 17.0
Unit type
Active 83.3 70.2 72.0 61.1
Guard 6.6 10.5 13.0 14.2
Reserve 10.1 19.3 16.0 24.7
Median age
in 1991
26 28 36 39
Age in
1991, years
!20 6.7 9.5 3.0 2.7
2024 34.3 25.2 15.0 8.7
2529 25.3 22.7 14.0 10.7
3034 15.4 16.0 14.0 12.1
3539 10.0 12.0 18.0 16.3
4044 5.6 8.7 18.0 20.1
4549 2.0 4.0 11.0 15.3
5054 0.6 1.4 5.0 8.6
5559 0.2 0.6 3.0 4.4
60þ 0.0 0.1 0.0 1.2
Median age
at diagnosis
45 48
Age at diagnosis,
years
!20 0.0 0.2
20-24 2.0 1.3
25-29 7.0 4.9
30-34 13.0 9.5
35-39 13.0 10.0
40-44 14.0 12.2
45-49 16.0 16.2
50-54 15.0 19.0
55-59 11.0 14.5
60þ 7.0 12.2
aInformation on this measure was missing for some veterans.
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The time trend shows a sharp relative excess of lung cancers
among the deployed veterans in 1993 and small relative
excess in 1995 and 1996. No deployment group related
differences are apparent from 1997 through 2003. For
2004 through 2006, the pattern shows a widening relative
excess in theGulfWar group. Online Supplemental Figure 1
illustrates the 95% CIs corresponding to the adjusted
proportions in Figure 1.
DISCUSSION
The finding that the proportion of cancers identified from
state registries was not statistically different between Gulf
War and non-Gulf War veterans, after controlling for age,
race and sex, is consistent with the UK incidence study
with similar methodology that showed no additional overall
risk of cancer among Gulf War veterans (5). Lung cancer
was the only specific cancer that showed a significant rela-
tive excess in the Gulf War group on the basis of PIR anal-
yses. Neither group showed a statistically significant excess
of lung cancer as compared with the general population
data from SEER.
TABLE 3. Proportional incidence ratios for cancer diagnoses among matched US Gulf War veterans compared with matched US
non-Gulf War veterans, 19912006
Primary site No. Gulf No. non-Gulf Total no.
Gulf War vs. non-Gulf War Grounda vs. non-Gulf War
PIRb 95% CI PIRb 95% CI
Oral cavity and pharynx 289 439 728 0.97 0.83–1.13 0.98 0.81–1.17
Esophagus 69 133 202 0.85 0.63–1.15 0.82 0.57–1.18
Stomach 133 169 302 1.17 0.93–1.48 1.21 0.93–1.57
Liver 50 97 147 0.73 0.52–1.04 0.67c 0.45–0.99
Gallbladder and pancreas 110 180 290 1.07 0.84–1.36 1.10 0.82–1.47
Other digestive system 841 1250 2091 1.07 0.97–1.18 1.03 0.92–1.15
Lung 620 966 1586 1.15c 1.03–1.29 1.21c 1.07–1.38
Other respiratory system 104 159 263 1.01 0.78–1.30 1.07 0.79–1.45
Bones and joints and soft tissue 172 208 380 1.04 0.85–1.29 0.95 0.73–1.23
Melanomas 749 1100 1849 0.98 0.89–1.09 0.99 0.87–1.12
Other skin 35 49 84 0.82 0.53–1.28 0.77 0.46–1.29
Breast (males) 12 24 36 0.78 0.39–1.58 0.61 0.24–1.57
Breast (females) 396 918 1314 1.01 0.86–1.20 1.00 0.82–1.21
Female genital system 238 520 758 0.94 0.77–1.15 0.90 0.71–1.13
Prostate 1397 2514 3911 1.01 0.93–1.10 1.00 0.91–1.11
Testis 496 590 1086 0.85c 0.75–0.98 0.85c 0.72–1.00
Other male genital system 35 32 67 1.55 0.95–2.53 1.73 0.97–3.09
Bladder 255 379 634 1.16 0.98–1.36 1.13 0.93–1.37
Other urinary system 264 459 723 0.87 0.74–1.01 0.89 0.74–1.07
Eye and orbit 20 30 50 1.06 0.60–1.90 1.46 0.70–3.02
Brain 278 410 688 0.86 0.73–1.01 0.86 0.71–1.04
Other nervous system 78 106 184 1.03 0.76–1.38 1.08 0.76–1.54
Endocrine system 301 433 734 0.95 0.82–1.11 0.93 0.77–1.12
Hodgkin lymphoma 239 245 484 1.10 0.91–1.33 1.12 0.89–1.40
Non-Hodgkin lymphoma
and chronic lymphocytic leukemia
478 671 1149 1.00 0.88–1.13 0.93 0.79–1.09
Multiple myeloma 83 125 208 1.03 0.78–1.37 1.03 0.75–1.43
Other leukemias 204 293 497 0.93 0.78–1.12 0.94 0.76–1.17
Mesothelioma 10 20 30 0.95 0.44–2.05 0.98 0.33–2.90
Kaposi sarcoma 46 85 131 0.54c 0.37–0.79 0.65 0.40–1.06
Ill-defined and unknown 209 260 469 1.17 0.97–1.42 1.21 0.96–1.52
Total cancers 8211 12,864 21,075
95% CIZ 95% confidence interval; PIRZ proportional incidence ratio.
aGround veterans were limited to Army and Marine branches.
bPIR derived from a logistic regression model controlling for sex, diagnosis age, diagnosis age squared, diagnosis year, race, branch of service, unit type, and registry group number.
cp ! .05.
TABLE 4. SIRsa and 95% CIs for US Gulf War and US non-
Gulf War Veterans, 19922005
Gulf War veterans Non-Gulf War veterans
Primary site SIR 95% CI SIR 95% CI
Lung 1.09 0.98–1.20 0.93 0.86–1.00
Testicular 0.95 0.86–1.05 1.10 1.0–1.20
Kaposi sarcoma 0.08 0.05–0.12 0.18 0.13–0.24
95% CIZ 95% confidence interval; SIR, standardized incidence ratio.
aAge-adjusted and includes only white male subjects; expected numbers calculated
from SEER incidence data 19922005.
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Data on smoking were not available for the cancer
matches, so the lung cancer analysis was not adjusted for
smoking patterns. However, Kang et al. (12) showed a signif-
icantly greater proportion of smokers among Gulf War
veterans as compared with non-Gulf War veterans (34.7%
vs. 29.9%) among 15,000 Gulf War and 15,000 non-Gulf
War veterans who were randomly sampled from the study
cohorts. Although confounding by cigarette smoking may
explain the difference in lung cancer between the Gulf
War and non-Gulf War group, the relative excess of lung
cancer among theGulfWar group, particularly the widening
relative excess for 2004 to 2006, suggests that a follow-up
study shouldbe conducted to confirm this finding and to eval-
uate the role of smoking.The length of follow-up in this study
was a maximum of 15 years, a relatively short latency period
for lung cancer. Various studies of air pollution and lung
cancer suggest latency periods of 20 to 30 years (18, 19).
The results in this study do not support the pilot study
findings of an increased proportion of testicular cancer
among Gulf War veterans (4). This study showed a signifi-
cantly lower relative proportion of testicular cancer among
the Gulf War veterans when compared with the non-Gulf
War veterans (PIR, 0.85; 95% CI, 0.750.98). However,
the results of this study are similar to those of Knoke et al.
(3), which showed that there was no overall difference in
the risk of testicular cancer between Gulf War and non-
Gulf War veterans. The pilot study (4) contained data
from only the District of Columbia and New Jersey and
examined a much shorter time period than the current
study. Knoke et al. (3) suggest that an immediate post-war
increase in testicular cancer among Gulf War veterans
may be attributable to an increased DOD health care utili-
zation among returning military personnel resulting from
deferment of care during deployment.
The overall findings in this study are consistent with find-
ings from the earlier Kang and Bullman (7) mortality study
performed in the same cohort of veterans. The authors noted
no significant excesses of overall cancer deaths or deaths
from specific cancers comparing Gulf War with non-Gulf
War veterans (7). The finding in this study of a significantly
decreased proportional rate of Kaposi sarcoma among the
Gulf War veterans is also supported by the previous
mortality study, which showed a significant deficit of deaths
attributable to HIV infection in Gulf War veterans (7). US
military personnel who screened positive for HIV, a known
risk factor of Kaposi sarcoma, were not deployed in the 1991
Gulf War. A more recent mortality study following this
cohort through 2004 also notes no significant excess of over-
all cancer deaths or deaths from cancers at any specific sites
and confirms the significant deficit of deaths due to HIV
infection in the Gulf War veterans (10).
Although mortality studies (9, 10) note increased risks of
brain cancer mortality among those exposed to the 1991
Khamisiyah chemical munitions destruction, our study did
not reveal any excess in brain cancer. However, these
mortality studies only showed significantly increased risk
when specific exposure variables detailing length of expo-
sure time were included in the models. Unlike the mortality
studies, this study did not have the specific Khamisiyah
exposure information available, and the brain cancer risk
associated with Khamisiyah chemical munitions destruction
could not be evaluated.
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FIGURE 1. Adjusted relative lung cancer proportions for US Gulf War and US non-Gulf War veterans, 1991 to 2006. Proportions were
adjusted for race, age at diagnosis, age at diagnosis squared, and sex and estimated at the mean for each covariate.
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Limitations
There were some limitations with the methodology of this
study. Because data from all 50 state cancer registries were
not available, this study did not look at true incidence rates
but was limited to examining match rates and proportional
incidence. Match rates underestimate true incidence, and
themain limitation of a PIR study is that a proportional inci-
dence for one cancer can be affected by the relative frequen-
cies of other types of cancers.
Another limitation is that the various registries used
a variety of linkage software andmethods. This may have re-
sulted in slightly different match rates between the regis-
tries. Issues of data quality in both state and DMDC
datasets were also a limitation. Although state registry
data is generally of high quality, data quality was variable
between registries and by year.
There is the possibility of duplication between states and
Veterans Affairs (VA) registries, but this possibility is very
small. At the time of the study, there would be little to no
overlap between state registries and the VACCR because
it was the policy of the VACCR to not allow state registries
to release data from VA facilities for research purposes (20).
Although the GulfWar and non-GulfWar veterans were
similar on the basis of race, the Gulf War veterans were
slightly younger, more likely to be male, and more likely
to be active duty than the non-Gulf War veterans. We
adjusted for race, sex, age, and status as appropriate in the
analysis, but there is the potential for residual confounding
by unmeasured variables. Those sent to the Gulf War may
have been healthier than those who were not sent. The
magnitude of this difference has been shown to be relatively
small and any differences in health status between GulfWar
and non-Gulf War soldiers were not apparent by the end of
the Gulf War (2).
There is a possibility of an excess in a rare cancer that was
missed as the result of small sample size. In addition, cancers
with long latency periods may not show excesses because of
the limited time period of study. The length of follow-up in
this study was limited to 15 years, which is a relatively short
latency period for some cancers. In addition, the age of the
veterans in this study was relatively young. The number of
certain types of cancers in this cohort may increase with
time as the cohort ages and the latency period lengthens;
therefore differences in relative excesses of particular types
of cancer may be underestimated in this study.
Finally, although we were able to perform linkages with
28 registries representing 84% of the US population, there
was concern about how representative the matches in the
28 linked states were of the potential cancer matches in
the remaining unlinked states. Any differences in character-
istics between linked and unlinked state matches were likely
the result of the fact that the states in which linkages were
performed represent larger and more urban population
centers and are not demographically representative of the
entire US population. Overall the limitations discussed
here were likely to nondifferentially underestimate the
true number of cancers in both the Gulf and non-Gulf
groups and result in an underestimate of the true risk.
Strengths
There are several strengths to this study. It was the first study
associating cancer incidence outcomes with the entire popu-
lation of Gulf War veterans and included a large and repre-
sentative sample of non-Gulf War veterans. The outcome
assessment was based on cancer registry data as opposed to
mortality, hospitalization, or self-reported cancer data. The
inclusion of the VACCR ensured that we had relatively
complete ascertainment of cancers that were diagnosed at
VA facilities. For more common cancers, the sample sizes
were large enough to provide adequate statistical power to
detect relatively small differences between groups.
CONCLUSIONS
This analysis demonstrated that there was no overall
increased proportional risk of cancer in Gulf War as
compared with non-Gulf War veterans. Lung cancer was
the only specific cancer that showed a significant relative
excess in the Gulf War veteran group. This relative excess
could be explained by differences in smoking patterns,
which were not measured in this study. It could also be
a real difference related to exposures in the Gulf War
theater. The time period in this study was a maximum of
15 years of follow-up, so additional studies should be con-
ducted to determine whether the relative excesses in lung
cancer increase or persist as the latency period from a poten-
tial Gulf War exposure increases.
The authors thank the staff from the state cancer registries that partici-
pated in the study and the staff of the VA Central Cancer Registry for
their contributions to this study.
SUPPLEMENTARY DATA
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.annepidem.
2009.11.012.
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Appendix. Supplemental Data
Cancer diagnosis data that was received from the state
cancer registries was deidentified. Therefore, although we
desired to analyze the cancer matches relative to the original
dataset of allGulf and non-Gulf veteranswe couldnot simply
merge the cancer diagnosis records with the originating data-
set. To address this limitation we created a dummy dataset
that would allow for the appropriate analyses to be
performed. This dataset was created with the same age,
gender, racial, and gulf distribution as the original dataset.
Only these variables were considered as they were the cova-
riates necessary for the analyses. This dataset included all the
cancer diagnosis data from state registries which were
matched on the aforementioned covariates. Logistic regres-
sion analyses were performed to determine the match rate
for any cancer diagnosis and for lung cancer diagnoses.
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SUPPLEMENTAL FIGURE 1. Confidence intervals on adjusted relative lung cancer proportions of cancers for US Gulf and US non-
Gulf veterans, 1991-2006. Proportions were adjusted for race, age at diagnosis, age at diagnosis squared, and gender, and estimated at the
mean or percent for each covariate; the middle dot on each line corresponds to the adjusted proportion presented in Figure 1.
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